SEOM–SERAM–SEMNIM guidelines on the use of functional and molecular imaging techniques in advanced non-small-cell lung cancer
- Fernández-Pérez, G. 7
- Sánchez-Escribano, R. 4
- García-Vicente, A.M. 9
- Luna-Alcalá, A. 18
- Ceballos-Viro, J. 10
- Delgado-Bolton, R.C. 23
- Vilanova-Busquets, J.C. 11
- Sánchez-Rovira, P. 5
- Fierro-Alanis, M.P. 6
- García-Figueiras, R. 6
- Alés-Martínez, J.E. 10
- 1 Clínica Las Nieves, Health Time, Jaén, Spain
-
2
Centro de Investigación Biomédica de La Rioja
info
-
3
Universidad de La Rioja
info
-
4
Complejo Asistencial Universitario de Burgos
info
-
5
Hospital Universitario de Jaén
info
-
6
Complexo Hospitalario Universitario de Santiago
info
Complexo Hospitalario Universitario de Santiago
Santiago de Compostela, España
-
7
Hospital Universitario Pío del Río Hortega
info
-
8
University Hospitals of Cleveland
info
-
9
Hospital General de Ciudad Real
info
- 10 Oncology Unit, Oncología Médica, Hospital Nuestra Señora de Sonsoles, Complejo Asistencial de Ávila, C/Avda, Juan Carlos I, s/n, Ávila, Spain
- 11 Servicio de Radiología, Instituto Catalán de Salud (IDI) Girona, Clinica Girona, Girona, Spain
ISSN: 1699-048X
Ano de publicación: 2017
Páxinas: 1-16
Tipo: Artigo
Outras publicacións en: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
Resumo
Imaging in oncology is an essential tool for patient management but its potential is being profoundly underutilized. Each of the techniques used in the diagnostic process also conveys functional information that can be relevant in treatment decision-making. New imaging algorithms and techniques enhance our knowledge about the phenotype of the tumor and its potential response to different therapies. Functional imaging can be defined as the one that provides information beyond the purely morphological data, and include all the techniques that make it possible to measure specific physiological functions of the tumor, whereas molecular imaging would include techniques that allow us to measure metabolic changes. Functional and molecular techniques included in this document are based on multi-detector computed tomography (CT), 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET), magnetic resonance imaging (MRI), and hybrid equipments, integrating PET with CT (PET/CT) or MRI (PET-MRI). Lung cancer is one of the most frequent and deadly tumors although survival is increasing thanks to advances in diagnostic methods and new treatments. This increased survival poises challenges in terms of proper follow-up and definitions of response and progression, as exemplified by immune therapy-related pseudoprogression. In this consensus document, the use of functional and molecular imaging techniques will be addressed to exploit their current potential and explore future applications in the diagnosis, evaluation of response and detection of recurrence of advanced NSCLC. © 2017 The Author(s)